Capsule can detect early stomach cancer

Nov 10, 2007

Researchers in Italy have developed a small capsule that can be used to detect early stomach cancer.

The University of Urbino said the capsule is coated in gelatin to make it slide down the throat on the end of a nylon thread. Once inside the stomach, the gelatin dissolves, letting gastric juices into the capsule through porous plastic walls, ANSA said Friday.

Lead researcher Pietro Musaro said cells from the stomach wall are absorbed by a tiny pad inside the capsule, which is then pulled out of the stomach. The substances can then be tested for the altered DNA found in stomach cancer.

Musaro said the capsule had a 98 percent success rate when tested on 20 patients with stomach tumors and 14 healthy volunteers, ANSA said.

The study is published in the Annals of Oncology.

Copyright 2007 by United Press International

Explore further: Older prostate cancer patients should think twice before undergoing treatment

add to favorites email to friend print save as pdf

Related Stories

Take two robots and call me in the morning

Jan 06, 2012

In the 1966 film "Fantastic Voyage," medical personnel board a submarine that shrinks to microscopic size and enters the bloodstream of a wounded diplomat to save his life.

Finnish firm to market cancer-prevention capsule

Jan 11, 2010

Finnish medical biotechnology group Biohit said Monday it had developed a capsule that could help prevent stomach and throat cancer by neutralising the cancer-causing compound acetaldehyde.

Recommended for you

CT radiation risk less than risk of examination indicator

16 hours ago

(HealthDay)—For young adults needing either a chest or abdominopelvic computed tomography (CT), the short-term risk of death from underlying morbidity is greater than the long-term risk of radiation-induced ...

User comments : 0

More news stories

Holding drivers' attention

Each day, an average of nine people are killed in the United States and more than 1,000 injured by drivers doing something other than driving.

Biomarker trio predicts near-term heart risk

(Medical Xpress)—Cardiologists have identified a trio of biomarkers that may predict which patients with heart disease have a high risk of heart attack or death in the next two years.